Quinoline-3-Carboxylic Acids "DNA Minor Groove-Binding Agent"

Area of Science:

• Medicinal Chemistry
• Computational Biology
• Molecular Biology

Background:

• Selected 2,4-disubstituted quinoline-3-carboxylic acid derivatives for in-silico study.
• Compounds demonstrated selectivity and potency against cancer cells.
• In-silico ADME data suggested favorable safety profiles.

Purpose of the Study:

• Correlate DNA-quinoline derivative interactions with in-vitro fluorescence microscopy data.
• Investigate the binding mechanism of quinoline derivatives with DNA.
• Provide insights into the drug action mechanism.

Main Methods:

• In-silico mechanistic study of lead quinoline compounds.
• Detailed interaction analysis with DNA dodecanucleotide d(CGCGAATTCGCG).
• Utilized computational modeling to predict binding modes and interactions.

Main Results:

• Confirmed binding of quinoline derivatives to the A/T minor groove of B-DNA.
• Identified key hydrogen bonds facilitating drug-DNA interaction.
• In-silico study supported sufficient binding energy and interactions with DNA.

Conclusions:

• Substitution at the 2nd position (carbonyl group) acts as a hydrogen bond donor/acceptor.
• Confirmed interaction pattern of quinoline derivatives with DNA.
• In-silico predictions provide a basis for further drug development.